- People
- Offices
- Practices
back- Practices
- Corporate, Finance and Investments
- back
- Corporate, Finance and Investments
- Activist Defense
- Alternative Capital and Credit Funds
- Capital Markets
- Construction and Procurement
- Corporate Governance
- Corporate, Finance and Investments
- Employee Benefits and Executive Compensation
- Energy and Infrastructure Projects
- Financial Restructuring
- Investment Funds and Asset Management
- Leveraged Finance
- Mergers and Acquisitions
- Middle East and Islamic Finance and Investment
- Private Equity
- Real Estate
- Securitization
- Tax
- Technology and Emerging Companies
- Government Matters
- Trial and Global Disputes
- back
- Trial and Global Disputes
- Appellate, Constitutional and Administrative Law
- Bankruptcy and Insolvency Litigation
- Class Action Defense
- Commercial Litigation
- Construction and Engineering Disputes
- Corporate and Securities Litigation
- E-Discovery
- Insurance Coverage and Recovery
- Intellectual Property, Patent, Trademark and Copyright Litigation
- International Arbitration and Litigation
- Labor and Employment
- Product Liability
- Professional Liability
- Toxic Tort and Environmental Litigation
- Trial and Global Disputes
- Careers
- News & Insights
- About
- Languages
Insight 46 results
Newsletter
May 18, 2018
Tokyo Dispute Resolution & Crisis Management Newsletter – May 2018
Client Alert
February 28, 2018
2017 Year in Review: FDA Office of Prescription Drug Promotion Warning and Untitled Letters
Client Alert
February 23, 2018
2017 Year in Review: FDA Medical Device Advertising and Promotion Warning and Untitled Letters
Article · Source: The Institute for Energy Law
February 15, 2018
Climate Change Litigation: The Emergence of Public Nuisance under (the Golden) State Law
Client Alert
Client Alert
December 14, 2017
FDA Releases Long-Awaited Guidances on the Regulation of Digital Health Tools
Client Alert
August 30, 2017
California’s Surprising New “No Surprise” Health Care Billing Law
Article · Source: Journal of Health Care Compliance
July 1, 2017
Sara Kay Wheeler Sheds Light on the Opioid Epidemic
Thought Leadership
June 1, 2017
King & Spalding to Host FinTech Roundtable With Sen. Tom Carper
Client Alert
April 11, 2017
SRS vs. Gilead Sciences: Delaware Court finding that "indication" means "disease" allows Gilead not to pay $50M Milestone
Client Alert
February 1, 2017
HHS Issues Final Rule that Substantially Revises the Federal Policy for the Protection of Human Subjects
Client Alert
January 26, 2017
FDA Defends Its First Amendment Position in “Memorandum”